Benitec Biopharma Inc expected to post a loss of $3.23 a share - Earnings Preview

Benitec Biopharma

29/08/2023 13:50

* Benitec Biopharma Inc  BNTC.OQ   BNTC.O  is expected
to show no
change in quarterly revenue when it reports  results on August
31 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Benitec Biopharma
Inc is
for a loss of $3.23 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Benitec
Biopharma
Inc is $68​, above​ its last closing price of $2.34. ​​​

This summary was machine generated August 29 at 12:50 GMT.  All
figures in US dollars  unless otherwise stated